Nabiximols (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nabiximols" in French language version.

refsWebsite
Global rank French rank
4th place
12th place
2nd place
3rd place
3,257th place
1,028th place
low place
low place
83rd place
2nd place
5,021st place
272nd place
1st place
1st place
194th place
17th place
87th place
20th place
243rd place
21st place
1,939th place
113th place
1,394th place
2,800th place

ama-assn.org

archive.is

doi.org

dx.doi.org

  • (en) Shaheen E Lakhan et Marie Rowland, « Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review », BMC Neurol, vol. 9,‎ , p. 59 (PMID 19961570, PMCID 2793241, DOI 10.1186/1471-2377-9-59)
  • (en) Wade D, Makela P, Robson P, House H, Bateman C, « Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients », Mult Scler, vol. 10, no 4,‎ , p. 434–41 (PMID 15327042, DOI 10.1191/1352458504ms1082oa)
  • (en) Wade D, Makela P, House H, Bateman C, Robson P, « Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis », Mult Scler, vol. 12, no 5,‎ , p. 639–45 (PMID 17086911, DOI 10.1177/1352458505070618)
  • (en) Wade D, Robson P, House H, Makela P, Aram J, « A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms », Clin Rehabil, vol. 17, no 1,‎ , p. 21–9 (PMID 12617376, DOI 10.1191/0269215503cr581oa)

googleusercontent.com

webcache.googleusercontent.com

gwpharm.com

lemonde.fr

  • Laetitia Clavreul et Chloé Hecketsweiler, « Le Sativex, médicament à base de cannabis, autorisé en France », Le Monde,‎ (lire en ligne)

mediapart.fr

nih.gov

ncbi.nlm.nih.gov

  • (en) Shaheen E Lakhan et Marie Rowland, « Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review », BMC Neurol, vol. 9,‎ , p. 59 (PMID 19961570, PMCID 2793241, DOI 10.1186/1471-2377-9-59)
  • (en) Wade D, Makela P, Robson P, House H, Bateman C, « Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients », Mult Scler, vol. 10, no 4,‎ , p. 434–41 (PMID 15327042, DOI 10.1191/1352458504ms1082oa)
  • (en) Wade D, Makela P, House H, Bateman C, Robson P, « Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis », Mult Scler, vol. 12, no 5,‎ , p. 639–45 (PMID 17086911, DOI 10.1177/1352458505070618)
  • (en) Wade D, Robson P, House H, Makela P, Aram J, « A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms », Clin Rehabil, vol. 17, no 1,‎ , p. 21–9 (PMID 12617376, DOI 10.1191/0269215503cr581oa)

publico.pt

sciencesetavenir.fr

web.archive.org

wikiwix.com

archive.wikiwix.com